These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9063378)

  • 1. The putative role of arylsulfatase in interleukin-2-mediated cytotoxicity and interleukin-7-mediated bactericidal activity of natural killer cells.
    Toren A; Gadish M; Fabian I; Nagler A
    Ann Hematol; 1997 Feb; 74(2):83-7. PubMed ID: 9063378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of resting and IL-2 activated NK cells to R-verapamil.
    Markham PN; Ellis TM; Tambur AR; Gebel HM
    Transplantation; 1996 Dec; 62(12):1883-8. PubMed ID: 8990381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old.
    Woods JA; Evans JK; Wolters BW; Ceddia MA; McAuley E
    J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B430-7. PubMed ID: 9823739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12.
    Wong EK; Eaves C; Klingemann HG
    Bone Marrow Transplant; 1996 Jul; 18(1):63-71. PubMed ID: 8831997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI; Brahmi Z
    Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
    Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
    Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
    Hellstrand K; Hermodsson S
    Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
    Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
    Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
    Törnroos H; Hägerstrand H; Lindqvist C
    Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxic effect of IL-2/IL-15 stimulated cord blood derived NK cells on K562/Jurkat cell lines].
    Zhang BH; Wu YF; Cen DY; Wei J; Liu Y; Chen C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):358-62. PubMed ID: 21518488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
    Seidel MG; Freissmuth M; Pehamberger H; Micksche M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):382-9. PubMed ID: 9774227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
    Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD
    Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry.
    Lin SJ; Cheng PJ; Huang YJ; Kuo ML
    Pediatr Allergy Immunol; 2004 Feb; 15(1):79-85. PubMed ID: 14998386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R; Bockstoce DC; Golub SH
    Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.